Through qRT-PCR and IHC, Choi et al. manifested that GRIA2 was significantly downregulated in advanced ovarian serous adenocarcinomas and the upregulation of GRIA2 was associated with the better survival of patients. Here, GRIA2 is linked to ovarian serous adenocarcinoma.